Start an enquiry ↗
Publications

Papers, notes & documents.

Plain-language articles, short white papers and the documents behind our supply — written by the EXOMIE team for formulators, researchers and clinicians.

9papers, dossiers & notes
Technical dossier

CICA EV™ — characterisation, safety & active delivery

Extracellular vesicles from Centella asiatica (Gotu kola), characterised by DLS, NTA, zeta potential, SEM, SDS-PAGE and ICP-MS, with a proof-of-concept Vitamin C loading and a 90-day stability study.

113.7 nmDLS Z-average · PDI 0.234
168.3 nmNTA median size (X50), ZetaView
~1.6×10¹⁰particles/mL by NTA
−8.5 mVmean zeta potential (SD 5.42)
75.4%Vitamin C loading efficiency (HPLC-UV)
< 0.005ppm As, Cd, Pb, Hg, Cr by ICP-MS
  • Morphology (SEM) — spherical to cup-shaped vesicles, about 50–200 nm, no aggregation observed
  • Protein profile (SDS-PAGE) — bands from about 10–150 kDa, enriched around 25–75 kDa
  • Safety screen — heavy metals below detection limits (nickel < 0.010 ppm)

90-day stability, three storage conditions

Stable at 2–8 °C: size 122.4 → 124.0 nm, loading 75.4 → 72.6%. Minimal change at room temperature. Gradual change under accelerated conditions (40 °C / 75% RH), within acceptable limits up to 60 days.

Particle size (DLS)

nm over 90 days

2–8 °C25 °C / 60% RH40 °C / 75% RH

Vitamin C encapsulation efficiency

% over 90 days

2–8 °C25 °C / 60% RH40 °C / 75% RH

Values as reported in the dossier (n = 3). Particle size is reported from separate measurements — DLS Z-average, NTA and the stability series — and these are not interchangeable.

Product evidence

Study summaries

Plain-language summaries of the studies behind Exonira. Each links to the full write-up, including limitations.

Short reads

White papers

Concise technical notes — each readable in a few minutes. Use your browser’s print function to save any section as a PDF.

White paper 01

Reading an exosome Certificate of Analysis

Every line of a COA, and why it is there.

  • Identity block — product, batch number, report, manufacture and expiry dates, volume, and processing notes such as 0.2 µm filter sterilisation or a stabiliser.
  • Appearance and pH — a first sanity check; pH is tied to vesicle stability (our batches: 5.17–5.5 against 5.0–6.0).
  • Protein by Bradford — used with the specification that 1 µg ≈ 1 billion EVs, so ≥ 2 µg/mL reads as at least 2 billion EVs/mL (our batches: 2.09–2.62 µg/mL).
  • Size distribution and SEM — median 30–200 nm and spherical, cup-shaped morphology.
  • Microbiology and metals — aerobic count, yeast and mould, E. coli, Salmonella, and lead, cadmium, mercury, arsenic, chromium, plus aflatoxin B1 for botanicals.
  • Method beside every result — the habit that makes batches comparable.
White paper 02

Planning a dose with standardised stock

From particles per mL to millilitres to order.

  • Choose a target dose in your finished product, in particles per mL.
  • Multiply by batch volume to get total particles required.
  • Divide by the stock concentration to get the volume of exosome stock — then check it is a sensible share of the batch.
  • Round total particles up to the minimum-order multiple (for catalogue plant exosomes, 1 × 10¹² particles).
  • Confirm stability and compatibility in your base. The calculator on the Bulk Supply page does the arithmetic.
White paper 03

Exonira: summary of the diabetic-foot-ulcer study

Design, findings and — importantly — limitations.

  • Prospective, open-label, non-randomised; 30 adults with Type 1 or 2 diabetes and a single ulcer (under 15 cm, Wagner grade ≤ 2); 5–10 drops once daily for 90 days.
  • Reported significant improvement (p < 0.05) in ulcer area, wound-evaluation score and lower-extremity function; no adverse events reported.
  • Limitations: small sample, no comparator, summary-level statistics; a larger randomised controlled trial is recommended.
  • Read the full evidence on the Exonira pages.
Long form

Articles

Four primers on the biology, sourcing, measurement and delivery of exosomes.

Article · 6 min

What are exosomes?

Biogenesis, cargo and why nanoscale messengers matter for regenerative science.

Every cell in the body — and in plants — releases tiny membrane-bound packages into its surroundings. The smallest, roughly 30 to 200 nanometres across, are called exosomes: about a thousand times narrower than a human hair, yet carrying RNA, proteins, lipids and metabolites from one cell to another.

How they form

Exosomes begin inside the cell. The surface membrane folds inward to make an early endosome; the endosome membrane buds inward again, creating small vesicles inside a larger multivesicular body. When that body fuses with the cell surface, the vesicles are released — these are exosomes. On the way, the cell sorts specific miRNA, siRNA, proteins and lipids into them, so the cargo is a selective snapshot of the parent cell rather than a random sample.

What they carry

  • miRNA, siRNA and other non-coding RNA that can tune gene expression in a recipient cell
  • Proteins, including tetraspanins used as identity markers
  • Lipids that give the membrane stability and influence uptake
  • DNA fragments and small metabolites that add further signals

Why they matter

Exosomes are cell-free: they deliver signals without transplanting whole cells. Their lipid membrane protects RNA from degradation and can help cargo cross biological barriers — properties that make them attractive for skin renewal, wound repair, delivery research and biomarker work.

Key pointExosomes are selectively loaded, nanoscale messengers. Their value depends on knowing source, size, concentration and cargo — which is what characterisation provides.
Article · 7 min

Plant, stem-cell or milk — which vesicle fits your work?

How the source shapes cargo, supply and best-fit applications.

Choosing a source is the first and most consequential decision in a programme. The same nanoscale architecture appears in plants, human stem cells and milk, but cargo, supply and context differ.

Plant-derived vesicles

Plants release exosome-like nanovesicles rich in lipids, proteins and small RNAs. They are abundant, scalable and vegan-friendly, and can be drawn from a wide range of botanicals — fruit, leaf, flower, seed, root. They suit cosmetics and daily-care formulations built on antioxidant, barrier and brightening concepts.

Stem-cell (MSC) vesicles

Mesenchymal stem cells from bone marrow, adipose tissue, umbilical cord or dental tissue secrete vesicles associated with repair and immune balance. Each tissue has a signature: adipose for angiogenic and matrix-remodelling signals, umbilical cord for high regenerative potency, dental tissue for neurotrophic cues. The trade-offs are higher cost, donor and culture variability, and a stricter regulatory context.

Milk and hemp vesicles

Cow-milk exosomes are abundant, lipid-rich and stable, which makes them a popular carrier in delivery research; they are animal-derived and labelled as such. Hemp-seed vesicles are plant-derived and lipid-rich, suited to barrier-nourishing concepts.

If you need…Start with
A broad antioxidant, barrier or brightening story with vegan sourcingPlant-derived
Regenerative or immune-balancing signalling from defined human tissueMSC-derived
A lipid-rich carrier for delivery researchMilk or hemp seed
Nucleotide-based repair supportPlant PDRN
Key pointMatch the source to the biological story and the regulatory context.
Article · 6 min

Characterising vesicles properly

What each test answers, and where each falls short.

No single measurement proves that a preparation is “exosomes”. Good practice — reflected in the MISEV guidelines — combines orthogonal methods, each answering a different question, and reports honestly what was measured.

Size and concentration

Nanoparticle tracking analysis (NTA) follows particles by their Brownian motion, giving a size distribution and a count per millilitre. It cannot tell vesicles from similar-sized particles such as protein aggregates. Dynamic light scattering (DLS) reports mean size, polydispersity and zeta potential — quick for batch consistency, less reliable for mixed populations.

Morphology

Electron microscopy shows the vesicles directly. TEM reveals internal structure (the familiar “cup shape” is partly a drying artefact); SEM shows surface morphology and lets individual diameters be measured. It is the reality check on NTA and DLS numbers.

Identity, purity and safety

  • Protein content (for example Bradford) and the particle-to-protein ratio indicate purity
  • Markers and RNA integrity support identity and cargo quality
  • Sterility, endotoxin, mycoplasma, microbial load — plus aflatoxin and pesticide screening for botanicals and heavy-metal limits — decide whether a batch is fit to use
Key pointUse several methods, read each for what it can and cannot prove, and insist on method-tagged results on the certificate.
Article · 6 min

From RNA to delivery: loading vesicles

Approaches to loading siRNA and miRNA — and proving it worked.

Exosomes naturally carry RNA, but many programmes want to deliver a specific one: a siRNA to silence a gene, or a miRNA mimic to tune a pathway. Loading it, and proving that it arrived intact, is a discipline of its own.

Loading strategies

  • Passive incubation — gentle but often low efficiency
  • Electroporation — an electric pulse transiently opens the membrane; efficient, but can aggregate RNA and stress vesicles
  • Sonication or extrusion — mechanical disruption followed by membrane recovery
  • Freeze–thaw cycles — mild permeabilisation
  • Chemical modification — for example cholesterol-conjugated siRNA that anchors in the bilayer
  • Endogenous loading — engineering the parent cell to package the RNA itself

Proving it worked

A common pitfall is mistaking RNA stuck on the outside, or aggregated with reagent, for RNA inside the vesicle. Good evidence includes nuclease-protection assays, controls that remove free RNA, and quantification by RT-qPCR or sequencing — from which encapsulation efficiency is calculated.

Beyond loading

Stability over time and temperature, release kinetics, and a functional read-out in cells (gene silencing, collagen, melanin, cytokines) complete the picture.

Key pointLoading is half the job. Protection, stability, release and function must each be measured before claiming delivery.
Download

Document library

Documents that accompany supply. Ask us for the full specification and documentation pack for any item.

Go deeper

References

  • Welsh JA et al. Minimal information for studies of extracellular vesicles (MISEV2023). J Extracell Vesicles 2024.
  • Théry C et al. MISEV2018. J Extracell Vesicles 2018.
  • Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013.
  • Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem 2019.
  • Dad HA et al. Plant exosome-like nanovesicles: emerging therapeutics and drug delivery nanoplatforms. Mol Ther 2021.
  • US FDA. Public safety notification on exosome products.
Start an enquiry

Need a paper we haven’t written?

Tell us the question — we’ll point you to the right document or write the note.